摘要
目的:探讨肾上腺能α1A受体阻滞剂在体外冲击波碎石术后排石效果。方法:112例患者体外冲击波碎石术后随机分为对照组(52例)及治疗组(60例),对照组服用排石颗粒,20 g/袋,3次/d;治疗组服用盐酸坦洛新缓释胶囊(肾上腺能α1A受体阻滞剂),0.4 mg,每天1次。治疗1个月后观察治疗效果。结果:对照组结石的排净率为75.5%,肾绞痛的发生率为36.7%,疼痛的天数(1.6±1.3)d;治疗组结石的排净率为89.6%,肾绞痛的发生率为22.4%,疼痛的天数(1.4±1.2)d。结论:肾上腺能α1A受体阻滞剂有利于小结石的排出并能减少ESWL后疼痛。
Objective:To study the efficacy of alpha1A adrenocepter antagonist for treatment of ureteral stone clearance after extracorporeal shockwave lithotripsy(ESWL).Methods:112 patients after ESWL were randomly divided into control group(52 cases) and treatment group(60 cases),in control group received Paishi granules 20g,po,tid,in treatment group received Tamsulosin Hydrochloride Sustained-release Capsules 0.4 mg,po,qn,and after treatment for 1 month observed curative effect.Results:the rate of ureteral stone clearance in control group and treatment group was 75.5%,89.6% respectively,incidence of renal colic was 36.7% and 22.4% respectively,days of painy of two group was(1.6±1.3) d and(1.4±1.2) d.Conclusion:Alpha1A adrenocepter antagonist is contribute to clear the ureteral stone and reduce pains after extracorporeal shockwave lithotripsy.
出处
《中国医药导报》
CAS
2010年第34期61-62,共2页
China Medical Herald
关键词
输尿管结石
Α1A受体阻滞剂
体外冲击波碎石术
排石颗粒
Ureteral stone
Alpha1A adrenocepter antagonist
Extracorporeal shockwave lithotripsy
Paishi granules